The bacteria Helicobacter pylori It affects two thirds of the world’s population and is identified as one of the main risk factors for gastric cancer. Furthermore, it often acts silently for years and can be resistant to conventional treatments, based on antibiotics.
Also, as indicated by the mayo clinicis related to the appearance of gastritis, damage to the protective mucosa of the stomach and small intestine and inflammation of the stomach mucosa.
The good news is that after 17 years of research, the Chilean scientist Apolinaria García Cancino -doctor in Biological Scienceswith specialization in Cellular and Molecular Biology and Master of Science with a mention in Microbiology and Biochemistry of the University of Concepción– developed capsules of natural origin from a probiotic that generate a better response to treatment.
These live microorganisms belong to the strain Lactobacillus yeast UCO-979C and its action was scientifically validated.
The study was published in the Electronic Journal of Biotechnology and went from a scientific innovation to an alternative available on the market.
The Chilean site 24 detailed that the product bears the name NUP! PyloriOFF and, in addition to the probiotic, it has vitamins and minerals as magnesium, zinc, folic acid (vitamin B9) and vitamin D2.
El poder del Lactobacillus yeast UCO-979C
About its innovation, Garcia Cancino said to the University of Concepciónas the A24 site replies: «This probiotic has the function of prevent Helicobacter pylori infectionmain risk factor for gastric cancer and helps regulate gastric microbiota”.
He also added: «It is a great achievement to see that after a long investigation, today it can contribute to a health problem in society. I am convinced that it is a duty for researchers to make a real contribution to the public, beyond scientific publications.»
The effectiveness of classic treatment against Helicobacter pylori
He Networked Biomedical Research Center published that a study of Clinical Gastroenterology and Hepatology indicates that after a first eradication attempt, 20% of patients remain infected with the virus. Helicobacter pylori .
With this new advance, these numbers are expected to be more encouraging.
Receive in your email all the news, stories and analysis from Clarín journalists
